Perspectives of surrogate decision makers for critically ill patients regarding gene variation research

Ellen Iverson, Aaron Celious, Carie R. Kennedy, Erica Shehane, Alexander Eastman, Victoria Warren, Bradley D. Freeman

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Purpose:We undertook this investigation to explore the manner in which surrogate decision makers for critically ill patients perceived genetic data collected in the context of clinical investigation.Methods:Surrogate decision makers for critically ill patients cared for in intensive care units of two urban hospitals participated in focus groups designed to explore perceptions regarding gene variation research.Results:Surrogate decision makers were generally familiar with genetic concepts and reported that they could provide an informed opinion regarding permitting (or declining) the participation of their loved ones in gene variation research. Respondents perceived the risk associated with this type of research largely as the risk associated with acquiring the sample (i.e., whether it involved an invasive procedure or not) but appreciated that genetic samples could provide information not readily obtained from nongenetic sources. Concerns about potential misuse of genetic data largely centered on misconduct, paternity, forensic applications, and insurance and employment discrimination. Although surrogate decision makers expressed that their loved ones would have interest in return of results and being recontacted for future use, these interests were secondary to confidentiality concerns.Conclusion:Respondents perceived genetic and nongenetic data as comparable. Informed consent processes that provide clear information regarding confidentiality protections, specimen handling, and parameters for future use may enhance enrollment.

Original languageEnglish (US)
Pages (from-to)368-373
Number of pages6
JournalGenetics in Medicine
Volume15
Issue number5
DOIs
StatePublished - May 2013

Fingerprint

Critical Illness
Confidentiality
Job Application
Research
Genetic Phenomena
Genes
Specimen Handling
Paternity
Urban Hospitals
Insurance
Focus Groups
Informed Consent
Intensive Care Units
Surveys and Questionnaires

Keywords

  • critical illness
  • focus groups
  • gene variation research
  • genetics
  • social science research
  • substituted judgment
  • surrogate decision maker

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Iverson, E., Celious, A., Kennedy, C. R., Shehane, E., Eastman, A., Warren, V., & Freeman, B. D. (2013). Perspectives of surrogate decision makers for critically ill patients regarding gene variation research. Genetics in Medicine, 15(5), 368-373. https://doi.org/10.1038/gim.2012.142

Perspectives of surrogate decision makers for critically ill patients regarding gene variation research. / Iverson, Ellen; Celious, Aaron; Kennedy, Carie R.; Shehane, Erica; Eastman, Alexander; Warren, Victoria; Freeman, Bradley D.

In: Genetics in Medicine, Vol. 15, No. 5, 05.2013, p. 368-373.

Research output: Contribution to journalArticle

Iverson, E, Celious, A, Kennedy, CR, Shehane, E, Eastman, A, Warren, V & Freeman, BD 2013, 'Perspectives of surrogate decision makers for critically ill patients regarding gene variation research', Genetics in Medicine, vol. 15, no. 5, pp. 368-373. https://doi.org/10.1038/gim.2012.142
Iverson, Ellen ; Celious, Aaron ; Kennedy, Carie R. ; Shehane, Erica ; Eastman, Alexander ; Warren, Victoria ; Freeman, Bradley D. / Perspectives of surrogate decision makers for critically ill patients regarding gene variation research. In: Genetics in Medicine. 2013 ; Vol. 15, No. 5. pp. 368-373.
@article{3d2e9a234dba465697260e4f543fc4f6,
title = "Perspectives of surrogate decision makers for critically ill patients regarding gene variation research",
abstract = "Purpose:We undertook this investigation to explore the manner in which surrogate decision makers for critically ill patients perceived genetic data collected in the context of clinical investigation.Methods:Surrogate decision makers for critically ill patients cared for in intensive care units of two urban hospitals participated in focus groups designed to explore perceptions regarding gene variation research.Results:Surrogate decision makers were generally familiar with genetic concepts and reported that they could provide an informed opinion regarding permitting (or declining) the participation of their loved ones in gene variation research. Respondents perceived the risk associated with this type of research largely as the risk associated with acquiring the sample (i.e., whether it involved an invasive procedure or not) but appreciated that genetic samples could provide information not readily obtained from nongenetic sources. Concerns about potential misuse of genetic data largely centered on misconduct, paternity, forensic applications, and insurance and employment discrimination. Although surrogate decision makers expressed that their loved ones would have interest in return of results and being recontacted for future use, these interests were secondary to confidentiality concerns.Conclusion:Respondents perceived genetic and nongenetic data as comparable. Informed consent processes that provide clear information regarding confidentiality protections, specimen handling, and parameters for future use may enhance enrollment.",
keywords = "critical illness, focus groups, gene variation research, genetics, social science research, substituted judgment, surrogate decision maker",
author = "Ellen Iverson and Aaron Celious and Kennedy, {Carie R.} and Erica Shehane and Alexander Eastman and Victoria Warren and Freeman, {Bradley D.}",
year = "2013",
month = "5",
doi = "10.1038/gim.2012.142",
language = "English (US)",
volume = "15",
pages = "368--373",
journal = "Genetics in Medicine",
issn = "1098-3600",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Perspectives of surrogate decision makers for critically ill patients regarding gene variation research

AU - Iverson, Ellen

AU - Celious, Aaron

AU - Kennedy, Carie R.

AU - Shehane, Erica

AU - Eastman, Alexander

AU - Warren, Victoria

AU - Freeman, Bradley D.

PY - 2013/5

Y1 - 2013/5

N2 - Purpose:We undertook this investigation to explore the manner in which surrogate decision makers for critically ill patients perceived genetic data collected in the context of clinical investigation.Methods:Surrogate decision makers for critically ill patients cared for in intensive care units of two urban hospitals participated in focus groups designed to explore perceptions regarding gene variation research.Results:Surrogate decision makers were generally familiar with genetic concepts and reported that they could provide an informed opinion regarding permitting (or declining) the participation of their loved ones in gene variation research. Respondents perceived the risk associated with this type of research largely as the risk associated with acquiring the sample (i.e., whether it involved an invasive procedure or not) but appreciated that genetic samples could provide information not readily obtained from nongenetic sources. Concerns about potential misuse of genetic data largely centered on misconduct, paternity, forensic applications, and insurance and employment discrimination. Although surrogate decision makers expressed that their loved ones would have interest in return of results and being recontacted for future use, these interests were secondary to confidentiality concerns.Conclusion:Respondents perceived genetic and nongenetic data as comparable. Informed consent processes that provide clear information regarding confidentiality protections, specimen handling, and parameters for future use may enhance enrollment.

AB - Purpose:We undertook this investigation to explore the manner in which surrogate decision makers for critically ill patients perceived genetic data collected in the context of clinical investigation.Methods:Surrogate decision makers for critically ill patients cared for in intensive care units of two urban hospitals participated in focus groups designed to explore perceptions regarding gene variation research.Results:Surrogate decision makers were generally familiar with genetic concepts and reported that they could provide an informed opinion regarding permitting (or declining) the participation of their loved ones in gene variation research. Respondents perceived the risk associated with this type of research largely as the risk associated with acquiring the sample (i.e., whether it involved an invasive procedure or not) but appreciated that genetic samples could provide information not readily obtained from nongenetic sources. Concerns about potential misuse of genetic data largely centered on misconduct, paternity, forensic applications, and insurance and employment discrimination. Although surrogate decision makers expressed that their loved ones would have interest in return of results and being recontacted for future use, these interests were secondary to confidentiality concerns.Conclusion:Respondents perceived genetic and nongenetic data as comparable. Informed consent processes that provide clear information regarding confidentiality protections, specimen handling, and parameters for future use may enhance enrollment.

KW - critical illness

KW - focus groups

KW - gene variation research

KW - genetics

KW - social science research

KW - substituted judgment

KW - surrogate decision maker

UR - http://www.scopus.com/inward/record.url?scp=84877261075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877261075&partnerID=8YFLogxK

U2 - 10.1038/gim.2012.142

DO - 10.1038/gim.2012.142

M3 - Article

C2 - 23154525

AN - SCOPUS:84877261075

VL - 15

SP - 368

EP - 373

JO - Genetics in Medicine

JF - Genetics in Medicine

SN - 1098-3600

IS - 5

ER -